APA (7th ed.) Citation

MO, K., FM, A., AM, B., E, H., RA, A., TI, A., . . . M, K. (2026). Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial. Pharmaceuticals (Basel, Switzerland), 19(4), . https://doi.org/10.3390/ph19040552

Chicago Style (17th ed.) Citation

MO, Khrieba, et al. "Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial." Pharmaceuticals (Basel, Switzerland) 19, no. 4 (2026). https://doi.org/10.3390/ph19040552.

MLA (9th ed.) Citation

MO, Khrieba, et al. "Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial." Pharmaceuticals (Basel, Switzerland), vol. 19, no. 4, 2026, https://doi.org/10.3390/ph19040552.